# Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen

> **NCT03582865** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 100 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Tamoxifen 20 mg

## Key facts

- **NCT ID:** NCT03582865
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-01
- **Primary completion:** 2020-09
- **Final completion:** 2020-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03582865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03582865, "Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03582865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*